Clinuvel Pharmaceuticals Ltd (CLVLY)
10.00
+0.04
(+0.45%)
USD |
OTCM |
Sep 23, 16:00
Clinuvel Pharmaceuticals Enterprise Value: 377.88M for Sept. 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 23, 2024 | 377.88M |
| September 20, 2024 | 375.63M |
| September 19, 2024 | 375.63M |
| September 18, 2024 | 367.11M |
| September 17, 2024 | 383.89M |
| September 16, 2024 | 377.88M |
| September 13, 2024 | 377.88M |
| September 12, 2024 | 372.87M |
| September 11, 2024 | 370.37M |
| September 10, 2024 | 360.35M |
| September 09, 2024 | 365.36M |
| September 06, 2024 | 349.09M |
| September 05, 2024 | 349.09M |
| September 04, 2024 | 379.38M |
| September 03, 2024 | 379.38M |
| August 30, 2024 | 392.90M |
| August 29, 2024 | 394.41M |
| August 28, 2024 | 349.51M |
| August 27, 2024 | 339.82M |
| August 26, 2024 | 340.32M |
| August 23, 2024 | 340.32M |
| August 22, 2024 | 324.80M |
| August 21, 2024 | 330.81M |
| August 20, 2024 | 335.82M |
| August 19, 2024 | 321.29M |
| Date | Value |
|---|---|
| August 16, 2024 | 345.33M |
| August 15, 2024 | 337.82M |
| August 14, 2024 | 347.83M |
| August 13, 2024 | 341.32M |
| August 12, 2024 | 345.83M |
| August 09, 2024 | 335.82M |
| August 08, 2024 | 332.56M |
| August 07, 2024 | 327.80M |
| August 06, 2024 | 338.82M |
| August 05, 2024 | 298.76M |
| August 02, 2024 | 350.34M |
| August 01, 2024 | 362.86M |
| July 31, 2024 | 372.37M |
| July 30, 2024 | 378.88M |
| July 29, 2024 | 377.88M |
| July 26, 2024 | 377.88M |
| July 25, 2024 | 365.36M |
| July 24, 2024 | 365.36M |
| July 23, 2024 | 390.90M |
| July 22, 2024 | 390.90M |
| July 19, 2024 | 387.40M |
| July 18, 2024 | 390.40M |
| July 17, 2024 | 387.40M |
| July 16, 2024 | 395.41M |
| July 15, 2024 | 395.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
298.76M
Minimum
Aug 05 2024
1.484B
Maximum
Sep 23 2021
680.25M
Average
641.09M
Median
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 7.780M |
| Immutep Ltd | -- |
| Opthea Ltd | 166.05M |
| Mesoblast Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | 4.58% |
| Operating Earnings Yield | 6.18% |
| Normalized Earnings Yield | 4.584 |